loading page

Ethanol worsens pathology and memory in the 5xFAD mouse model of Alzheimer's disease
  • +3
  • Linh Le,
  • Rebecca Lowery,
  • Nisha Arya,
  • Florence Varodayan,
  • M. Kerry O'Banion,
  • Ania Majewska
Linh Le
University of Rochester
Author Profile
Rebecca Lowery
University of Rochester
Author Profile
Nisha Arya
University of Rochester
Author Profile
Florence Varodayan
SUNY Binghamton
Author Profile
M. Kerry O'Banion
University of Rochester
Author Profile
Ania Majewska
University of Rochester

Corresponding Author:ania_majewska@urmc.rochester.edu

Author Profile

Abstract

Alzheimer’s disease (AD) is the most common age-related dementia. Lifestyle factors, including alcohol use, can increase the risk of AD. While human studies demonstrate that alcohol use can negatively impact AD risk and disease progression, the underlying alcohol-dependent mechanisms that increase neurodegeneration and Aβ burden remain elusive. We have recently shown that alcohol can acutely affect microglial dynamics, which are critical to microglial function, and many other studies have reported inflammatory activation of microglia after long-term alcohol exposure in both humans and animal models. Here, we administered ethanol at dosages that mimic human binge drinking for 4 weeks to 2.5-month-old male 5xFAD mice, a common mouse model of AD. After a two-week abstinence period, we performed behavior assays and analyzed amyloid pathology and microglial morphology in the subiculum where amyloid pathology develops earlier than in other brain regions. We found that ethanol exposure facilitated amyloid pathology and worsened cognitive function in 5xFAD mice, while microglial arborization and phagocytosis appeared unchanged. Overall, our results suggest that pronounced ethanol exposure, when started early in the disease before amyloid pathology is established, can worsen AD progression in an amyloidosis model.
26 Nov 2024Submitted to European Journal of Neuroscience
29 Nov 2024Submission Checks Completed
29 Nov 2024Assigned to Editor
01 Dec 2024Review(s) Completed, Editorial Evaluation Pending
01 Dec 2024Reviewer(s) Assigned